Braun and colleagues (35) reported that around 35% of seronegative SARS-CoV-2-unexposed healthy donors had CD4+ T cells that were reactive mainly against the C-terminal portion of the SARS-CoV-2-S protein, although this was a lower proportion than in COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.